Cargando…

Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis

BACKGROUND: During atherogenesis, cholesterol precipitates into cholesterol crystals (CC) in the vessel wall, which trigger plaque inflammation by activating the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome. We investigated the relationship between CC, complement and NLRP3 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niyonzima, Nathalie, Bakke, Siril S., Gregersen, Ida, Holm, Sverre, Sandanger, Øystein, Orrem, Hilde L., Sporsheim, Bjørnar, Ryan, Liv, Kong, Xiang Yi, Dahl, Tuva Børresdatter, Skjelland, Mona, Sørensen, Kirsten Krohg, Rokstad, Anne Mari, Yndestad, Arne, Latz, Eicke, Gullestad, Lars, Andersen, Geir Ø., Damås, Jan Kristian, Aukrust, Pål, Mollnes, Tom E., Halvorsen, Bente, Espevik, Terje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494683/ https://www.ncbi.nlm.nih.gov/pubmed/32927275 http://dx.doi.org/10.1016/j.ebiom.2020.102985

Ejemplares similares

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
por: Gregersen, Ida, et al.
Publicado: (2017)

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
por: Orrem, Hilde L., et al.
Publicado: (2018)

Toll-Like Receptor 9 Mediated Responses in Cardiac Fibroblasts
por: Ohm, Ingrid Kristine, et al.
Publicado: (2014)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis
por: Abbas, Azhar, et al.
Publicado: (2014)

Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018)

Increased Systemic and Local Interleukin 9 Levels in Patients with Carotid and Coronary Atherosclerosis
por: Gregersen, Ida, et al.
Publicado: (2013)

Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation
por: Otterdal, Kari, et al.
Publicado: (2015)

Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke
por: Holm, Sverre, et al.
Publicado: (2011)

Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
por: Orrem, Hilde L., et al.
Publicado: (2018)

Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack
por: Skarpengland, Tonje, et al.
Publicado: (2018)

Targeting the Inflammasome in Cardiovascular Disease
por: Olsen, Maria Belland, et al.
Publicado: (2021)

The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
por: Yndestad, Arne, et al.
Publicado: (2012)

Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
por: Dhondup, Yangchen, et al.
Publicado: (2015)

Cytokines as new treatment targets in chronic heart failure
por: Damås, Jan Kristian, et al.
Publicado: (2001)

Importance of extra- and intracellular domains of TLR1 and TLR2 in NFκB signaling
por: Sandor, Frantisek, et al.
Publicado: (2003)

Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts
por: Torp, May-Kristin, et al.
Publicado: (2019)

Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
por: Dhondup, Yangchen, et al.
Publicado: (2017)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023)

The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017)

Allyl Isothiocyanate Inhibits Actin-Dependent Intracellular Transport in Arabidopsis thaliana
por: Sporsheim, Bjørnar, et al.
Publicado: (2015)

Endonuclease V Regulates Atherosclerosis Through C‐C Motif Chemokine Ligand 2‐Mediated Monocyte Infiltration
por: Kong, Xiang Yi, et al.
Publicado: (2021)

Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017)

Patient Derived Colonoids as Drug Testing Platforms–Critical Importance of Oxygen Concentration
por: Skovdahl, Helene Kolstad, et al.
Publicado: (2021)

Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease
por: Berg, Janna, et al.
Publicado: (2018)

Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsis
por: Hellerud, Bernt C., et al.
Publicado: (2017)

Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma
por: Kong, Xiang Yi, et al.
Publicado: (2020)

Markers of extracellular matrix remodeling and systemic inflammation in patients with heritable thoracic aortic diseases
por: Seim, Bjørn Edvard, et al.
Publicado: (2022)

Highly variable effect of sonication to dislodge biofilm-embedded Staphylococcus epidermidis directly quantified by epifluorescence microscopy: an in vitro model study
por: Sandbakken, Erik T., et al.
Publicado: (2020)

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
por: Barratt-Due, Andreas, et al.
Publicado: (2016)

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
por: Bertheloot, Damien, et al.
Publicado: (2017)

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy
por: Abraityte, Aurelija, et al.
Publicado: (2017)

Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction: Potential Counteracting Effects of Activin A on Inflammation
por: Andersen, Geir Ø., et al.
Publicado: (2011)

Electronic optional guidelines as a tool to improve the process of referring patients to specialized care: An intervention study
por: Rokstad, Ingrid S., et al.
Publicado: (2013)

TAK1ng control: TAK1 restrains NLRP3 activation
por: Mangan, Matthew Stephen, et al.
Publicado: (2018)

Lack of Chemokine Signaling through CXCR5 Causes Increased Mortality, Ventricular Dilatation and Deranged Matrix during Cardiac Pressure Overload
por: Waehre, Anne, et al.
Publicado: (2011)

The Homeostatic Chemokine CCL21 Predicts Mortality in Aortic Stenosis Patients and Modulates Left Ventricular Remodeling
por: Finsen, Alexandra Vanessa, et al.
Publicado: (2014)

Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2019)

Allyl isothiocyanate depletes glutathione and upregulates expression of glutathione S-transferases in Arabidopsis thaliana
por: Øverby, Anders, et al.
Publicado: (2015)

Microvascular function and inflammatory activation in Takotsubo cardiomyopathy
por: Solberg, Ole Geir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gsv47v7i5pi9g9u36v9fkfa2d0